• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2010-2019  
Title Created Date
Somatostatin receptor subtypes in hormone-refractory (castration-resistant) prostatic carcinoma 17 July 2014
Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer 17 July 2014
Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase 15 July 2014
Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin 14 July 2014
Somatostatin analogs: does pharmacology impact antitumor efficacy? 11 July 2014
Somatostatin (SS), SS receptors and SS analog treatment in tumorigenesis 11 July 2014
Can Melatonin Help Us in Radiation Oncology Treatments? 07 July 2014
Somatostatin receptors 3, 4 and 5 play important roles in gallbladder cancer 04 July 2014
The role of vitamin D in reducing cancer risk and progression 03 July 2014
Somatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and Therapeutics 03 July 2014
Display # 

Page 159 of 172

  • Start
  • Prev
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • Next
  • End

Search

Follow us...

Latest

  • Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study
  • Apoptotic effect of melatonin on ER-positive breast cancer cell lines: ADGRL4 gene expression and promoter methylation
  • Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells
  • Melatonin hybrids as multifunctional therapeutic agents: A comprehensive review
  • Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review
  • Melatonin: an essential factor for the treatment and recovery from leukemia and cancer
  • Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells
  • Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer
  • Melatonin as a potential inhibitory agent in head and neck cancer
  • Co-expression of GH and GHR isoforms in prostate cancer cell lines
  • Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
  • Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells
  • Vitamin D deficiency
  • Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines
  • Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
  • Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats
  • Molecular aspects of melatonin (MLT)-mediated therapeutic effects
  • Breast Cancer and Prolactin - New Mechanisms and Models

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • How effective is chemo therapy?
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Vademecum
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer